Recent findings suggest that chronic anticholinergic burden may hasten or contribute to a neurodegenerative process. APOE ε4 carrier status may be a genetic risk factor for vulnerability to ...
and reflect the effects of cumulative anticholinergic burden. Common nonspecific adverse effects on the CNS include headache, pain, anxiety and insomnia. With higher anticholinergic concentrations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback